Micra transcatheter pacing system (MTPS) is an emerging technology successfully validated in clinical trials and post-approval registry.
| INTRODUC TI ON
Micra transcatheter pacing system (MTPS) is an emerging technology successfully validated in clinical trials and post-approval registry. [1] [2] [3] However, along the growing experience, unexpected pitfalls may come up resulting in a major challenge for the operator.
| C A S E REP ORT
A 77-year-old patient, with permanent atrial fibrillation, diabetes mellitus, and chronic renal disease, underwent MTPS implantation by the means of the standard and recommended technique.
Once advanced the delivery system and reached the proper position, MTPS was successfully implanted in the midseptum at the first deployment. Optimal electrical parameters (0.88 V at 0.24 ms pacing threshold, 12 mV sensing, 680 Ohm impedance) and tug test confirmed the successful implantation. Once the pull-back of the tether to release MTPS begun, an increasing step-by-step resistance was felt by the operator until to complete blockage, despite successful testing of both sides of the tether before cutting and an ongoing heparinized saline at 400ml/h flow rate. A challenging recapture of MTPS into the delivery system was performed with a strong traction along the single tether (Video S1). A new MTPS was successfully implanted. Examining the retrieved MTPS, we observed a surprising indissoluble knot (Figure 1 ; Video S2) close to the docking button that blocked the running of the tether, and a long clot inside the delivery system.
| D ISCUSS I ON
Clot formation at the tip of Micra as well as inside the delivery system is not a new finding despite infusion of heparinized solution After the experience reported, we performed MTPS implantation by changing our technique and we did not have encountered any problems. Now for every procedure, after Micra deployment, just after cutting the tether we close the inner flushing tube with a finger to favor the antegrade flow along the main body of the delivery and we flush the system under pressure through the port access by using a syringe with heparinized saline. Since august 2018, we have adopted this technique resulting in faster tether retrieval, without clot formation and without knot formation.
A recent technological update of the internal structure of the delivery system has been introduced ( Figure 2) , with a new inner assembly and a new design of internal handle components. The inner lumens changed from 4 lumens to 3 lumens with lumen common to flush and tether (Video S4), and the lumen material changed from PTFE to PFA. Whether this change is involved in the mechanism of knot formation is still unknown, but the knot formation is a recent finding.
We suggest reconsideration of the standard recommendations about delivery system flushing and to evaluate technological improvement of the inner flushing tube system.
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